- Article metrics
- Last updated: Thu, 9 Oct 2025 17:53:44 Z
In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis
Access & Citations
-
- 3087
- Article Accesses
-
- 0
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 3 tweeters
- 3 blogs
- 1 Facebook pages
- 9 news outlets
- 5 Mendeley
This article is in the 97th percentile (ranked 6,902nd) of the 331,088 tracked articles of a similar age in all journals and the 92nd percentile (ranked 194th) of the 2,613 tracked articles of a similar age in Nature Communications
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
New Tool Predicts MS Medication Effectiveness
Mirage News -
研究人员开发工具来预测患者将如何应对常见多发性硬化症药物
Mandarinian -
研究者は、患者が一般的な多発性硬化症薬にどのように反応するかを予測するツールを開発します
Nipponese.news -
Guessing why natalizumab doesn’t work for everybody.
Multiple Sclerosis Research
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.